Literature DB >> 20687117

Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology.

Roy Hamilton1, Sunil Patel, Edward B Lee, Eric M Jackson, Joanna Lopinto, Steven E Arnold, Christopher M Clark, Anuj Basil, Leslie M Shaw, Sharon X Xie, M Sean Grady, John Q Trojanowski.   

Abstract

To determine the impact of cortical Alzheimer disease pathology on shunt responsiveness in individuals treated for idiopathic normal pressure hydrocephalus (iNPH), 37 patients clinically diagnosed with iNPH participated in a prospective study in which performance on neurologic, psychometric, and gait measures before and 4 months after shunting was correlated with amyloid β plaques, neuritic plaques, and neurofibrillary tangles observed in cortical biopsies obtained during shunt insertion. No complications resulted from biopsy acquisition. Moderate to severe pathology was associated with worse baseline cognitive performance and diminished postoperative improvement on NPH symptom severity scales, gait measures, and cognitive instruments compared to patients lacking pathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20687117      PMCID: PMC2964442          DOI: 10.1002/ana.22015

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

1.  Three-year survival and functional outcome of patients with idiopathic adult hydrocephalus syndrome.

Authors:  J Malm; B Kristensen; B Stegmayr; M Fagerlund; L O Koskinen
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

2.  Secretion and intracellular generation of truncated Abeta in beta-site amyloid-beta precursor protein-cleaving enzyme expressing human neurons.

Authors:  Edward B Lee; Daniel M Skovronsky; Farhad Abtahian; Robert W Doms; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2002-12-11       Impact factor: 5.157

3.  Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness.

Authors:  M K Holden; K M Gill; M R Magliozzi; J Nathan; L Piehl-Baker
Journal:  Phys Ther       Date:  1984-01

4.  Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response.

Authors:  J Golomb; J Wisoff; D C Miller; I Boksay; A Kluger; H Weiner; J Salton; W Graves
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

5.  Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease.

Authors:  Thomas McBride; Paul J Moberg; Steven E Arnold; Lyn Harper Mozley; Richard N Mahr; Maureen Gibney; Anand Kumar; Raquel E Gur
Journal:  Schizophr Res       Date:  2002-06-01       Impact factor: 4.939

6.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

7.  Is the placement of shunts in patients with idiopathic normal-pressure hydrocephalus worth the risk? Results of a study based on continuous monitoring of intracranial pressure.

Authors:  Maria A Poca; Maria Mataró; Maria Del Mar Matarín; Fuat Arikan; Carmen Junqué; Juan Sahuquillo
Journal:  J Neurosurg       Date:  2004-05       Impact factor: 5.115

8.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

9.  Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

Authors:  John E Duda; Benoit I Giasson; Meghann E Mabon; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

10.  Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404.

Authors:  L Otvos; L Feiner; E Lang; G I Szendrei; M Goedert; V M Lee
Journal:  J Neurosci Res       Date:  1994-12-15       Impact factor: 4.164

View more
  46 in total

1.  Dynamic analysis of amyloid β-protein in behaving mice reveals opposing changes in ISF versus parenchymal Aβ during age-related plaque formation.

Authors:  Soyon Hong; Omar Quintero-Monzon; Beth L Ostaszewski; Daniel R Podlisny; William T Cavanaugh; Ting Yang; David M Holtzman; John R Cirrito; Dennis J Selkoe
Journal:  J Neurosci       Date:  2011-11-02       Impact factor: 6.167

2.  Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases.

Authors:  Sriram Venneti; John L Robinson; Subhojit Roy; Matthew T White; Jennifer Baccon; Sharon X Xie; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2011-09-30       Impact factor: 17.088

Review 3.  A review of cognitive impairment and differential diagnosis in idiopathic normal pressure hydrocephalus.

Authors:  Marta Picascia; Roberta Zangaglia; Sara Bernini; Brigida Minafra; Elena Sinforiani; Claudio Pacchetti
Journal:  Funct Neurol       Date:  2015 Oct-Dec

Review 4.  Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  John J Halperin; Roger Kurlan; Jason M Schwalb; Michael D Cusimano; Gary Gronseth; David Gloss
Journal:  Neurology       Date:  2015-12-08       Impact factor: 9.910

5.  Co-occurrence of parkinsonism and dementia in clinical practice: relevant differential diagnoses.

Authors:  I Liepelt-Scarfone; M Jamour; W Maetzler
Journal:  Z Gerontol Geriatr       Date:  2012-01       Impact factor: 1.281

Review 6.  The use of cerebrospinal fluid and neuropathologic studies in neuropsychiatry practice and research.

Authors:  Kalyani Kansal; David J Irwin
Journal:  Psychiatr Clin North Am       Date:  2015-03-18

7.  Cerebral bleed after shunt for normal pressure hydrocephalus with cerebral amyloid angiopathy: Coincidence or consequence?

Authors:  Eric McDade; Brendon P Boot; Mario Riverol; Oscar Lopez
Journal:  Neurol Clin Pract       Date:  2015-06

8.  Prognostic value of amyloid PET scan in normal pressure hydrocephalus.

Authors:  Hyemin Jang; Seong Beom Park; Yeshin Kim; Ko Woon Kim; Jung Il Lee; Sung Tae Kim; Kyung Han Lee; Eun-Suk Kang; Yeong Sim Choe; Sang Won Seo; Hee Jin Kim; Yeo Jin Kim; Cindy W Yoon; Duk L Na
Journal:  J Neurol       Date:  2017-11-11       Impact factor: 4.849

9.  Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology.

Authors:  David A Wolk; Igor D Grachev; Chris Buckley; Hala Kazi; M Sean Grady; John Q Trojanowski; Roy H Hamilton; Paul Sherwin; Richard McLain; Steven E Arnold
Journal:  Arch Neurol       Date:  2011-07-11

10.  Neocortical β-amyloid area is associated with dementia and APOE in the oldest-old.

Authors:  Daniel J Berlau; María M Corrada; John L Robinson; Felix Geser; Steven E Arnold; Virginia M-Y Lee; Claudia H Kawas; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2013-03-07       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.